BGI Genomics Co Ltd (300676)

Shenzhen
Currency in CNY
50.00
-1.11(-2.17%)
Closed·
300676 Scorecard
Full Analysis
Management has been aggressively buying back shares
300676 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
49.8051.35
52 wk Range
33.3370.30
Key Statistics
Edit
Bid/Ask
50.00 / 50.00
Prev. Close
51.11
Open
50.87
Day's Range
49.8-51.35
52 wk Range
33.33-70.3
Volume
5.63M
Average Volume (3m)
6.36M
1-Year Change
30.97%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300676 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
52.19
Upside
+4.38%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

BGI Genomics Co Ltd News & Analysis

Show more

BGI Genomics Co Ltd Company Profile

BGI Genomics Co., Ltd. provides genomic sequencing and proteomic services in China and internationally. The company offers solutions to various applications, such as basic research covering human, plant, animal, and microbial species; clinical research in human health; genetic testing and screening; drug discovery and development; and agriculture and biodiversity preservation and sustainability. It provides DNA, RNA, and customized sequencing solutions; and mass spec services, as well as COVID-19 PCR test kits and COVID lab solutions. In addition, the company offers diagnostics and precision medicines for COVID-19, infectious diseases, and oncology. It serves academic institutions, pharmaceutical companies, health care providers, and other organizations. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China. BGI Genomics Co., Ltd operates as a subsidiary of BGI Group.

Employees
3702
Market
China

Compare 300676 to Peers and Sector

Metrics to compare
300676
Peers
Sector
Relationship
P/E Ratio
−19.8x−6.3x−0.5x
PEG Ratio
0.010.220.00
Price/Book
2.1x3.4x2.6x
Price / LTM Sales
5.2x10.0x3.1x
Upside (Analyst Target)
4.4%29.1%48.3%
Fair Value Upside
Unlock−5.0%7.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 52.19
(+4.38% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -2.34%
Dividend Yield
0.20%
Industry Median 0.66%
Annualized payout
0.10
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
-0.13 / --
Revenue / Forecast
672.00M / --
EPS Revisions
Last 90 days

300676 Income Statement

People Also Watch

95.85
9926
+0.42%
58.00
1024
-0.94%
72.40
9868
-5.17%
248.20
300750
-0.64%
138.20
3690
-1.99%

FAQ

What Is the BGI Genomics (300676) Stock Price Today?

The BGI Genomics stock price today is 50.00

What Stock Exchange Does BGI Genomics Trade On?

BGI Genomics is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for BGI Genomics?

The stock symbol for BGI Genomics is "300676."

Does BGI Genomics Pay Dividends? What’s The Current Dividend Yield?

The BGI Genomics dividend yield is 0.2%.

What Is the BGI Genomics Market Cap?

As of today, BGI Genomics market cap is 19.18B.

What Is BGI Genomics's Earnings Per Share (TTM)?

The BGI Genomics EPS (TTM) is -2.34.

When Is the Next BGI Genomics Earnings Date?

BGI Genomics will release its next earnings report on Aug 22, 2025.

From a Technical Analysis Perspective, Is 300676 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BGI Genomics Stock Split?

BGI Genomics has split 0 times.

How Many Employees Does BGI Genomics Have?

BGI Genomics has 3702 employees.

What is the current trading status of BGI Genomics (300676)?

As of Jun 13, 2025, BGI Genomics (300676) is trading at a price of 50.00, with a previous close of 51.11. The stock has fluctuated within a day range of 49.80 to 51.35, while its 52-week range spans from 33.33 to 70.30.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.